Autoimmune hemolysis: a critical review.

Area of Science:

• Immunology
• Hematology

Background:

• Autoimmune hemolysis is characterized by autoantibodies targeting erythrocytes, leading to shortened red blood cell lifespan.
• Autoantibody production is linked to reduced suppressor T lymphocyte activity.
• Erythrocyte destruction rate depends on autoantibody characteristics and complement/mononuclear phagocyte system activity.

Purpose of the Study:

• To define autoimmune hemolysis and its underlying mechanisms.
• To classify the different types of autoimmune hemolysis.
• To review current and potential future treatment strategies.

Main Methods:

• Review of existing literature on autoimmune hemolysis.
• Classification based on autoantibody type (warm, cold, mixed).
• Discussion of treatment modalities including immunosuppression, surgery, plasma exchange, and transfusion.

Main Results:

• Anemia occurs when red blood cell destruction exceeds marrow production.
• Primary and secondary autoimmune hemolysis are recognized.
• Specific types like those associated with pregnancy and Donath-Landsteiner antibodies are detailed.

Conclusions:

• Autoimmune hemolysis is a complex condition with varied causes and presentations.
• Current treatments focus on managing autoantibody production and erythrocyte destruction.
• Immunomanipulation represents a promising future therapeutic avenue.